FDA approves at-home, non-presecription COVID-19 tests – UPI.com

The U.S. Food and Drug Administration has approved two more at-home COVID-19 screening tests that can be purchased over-the-counter.

The FDA made the announcement in a release Thursday, stating the approvals were given to “get more tests for screening asymptomatic individuals on the market.”

The federal agency approved BinaxNOW COVID-19 Antigen Self Test by Abbott Laboratories, a U.S. medical device company, and QuickVue At-Home OTC COVID-19 test by Quidel Corporation, a U.S. diagnostics healthcare products manufacturer.

It also approved a third test, BD Veritor System’s Rapid Detection of SARS-CoV-2, for use in point-of-care settings.

Source: FDA approves at-home, non-presecription COVID-19 tests – UPI.com